# Quantum Pharma Holdings (Quantum Pharma Holdings Limited)

Private limited company registered in Bloomsbury, classed under “Activities of head offices”.

- Company number: 09269818
- Status: Active
- Type: Private limited company
- Incorporated: 17 October 2014
- Registered office: 25 Bedford Square, Bloomsbury, London, WC1B 3HH
- Location: Bloomsbury, London
- Activity: Activities of head offices

## Latest filed profit

No profit figure in its latest filed accounts.

Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers.

## Questions people ask

### What does Quantum Pharma Holdings do?

Private limited company registered in Bloomsbury, classed under “Activities of head offices”.

### How much turnover does Quantum Pharma Holdings make?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/quantum-pharma-holdings-09269818

### Is Quantum Pharma Holdings profitable?

Quantum Pharma Holdings's profit isn't public: small companies may file without a profit and loss account.

### Who runs and owns Quantum Pharma Holdings?

Its directors are Richard Edward Adair, Stephanie Jane Brooksbank, Richard John Paling. Its owners are shown to subscribers.

### Where is Quantum Pharma Holdings based?

Its registered office is 25 Bedford Square, Bloomsbury, London, WC1B 3HH, in Bloomsbury, London.

### When was Quantum Pharma Holdings founded?

Quantum Pharma Holdings Limited was incorporated on 17 October 2014.

### Is Quantum Pharma Holdings still trading?

The register lists Quantum Pharma Holdings Limited as active.

## Timeline

Recent filings and changes at Companies House.

- 2026-10-16: Termination of appointment of Varun Sethi as a director on 5 October 2026
- 2026-06-30: Statement by Directors (and 7 more like it since 10 December 2020)
- 2026-06-30: Statement of capital on 30 June 2026 · GBP 1.00 (and 1 more like it since 19 June 2026)
- 2026-06-30: Solvency Statement dated 29/06/26
- 2026-06-30: Resolutions (and 11 more like it since 1 December 2016)
- 2026-06-19: Solvency Statement dated 17/06/26
- 2026-06-17: Appointment of Ms Stephanie Jane Brooksbank as a director on 28 April 2026
- 2026-04-09: Audit exemption subsidiary accounts made up to 30 June 2025
- 2026-04-09: Consolidated accounts of parent company for subsidiary company period ending 30/06/25
- 2026-04-09: Notice of agreement to exemption from audit of accounts for period ending 30/06/25
- 2026-01-29: Appointment of Mr Varun Sethi as a director on 22 January 2026
- 2025-10-21: Termination of appointment of Jerome Marie Joseph Charton as a director on 8 October 2025
- 2025-03-25: Audit exemption subsidiary accounts made up to 30 June 2024
- 2025-03-25: Consolidated accounts of parent company for subsidiary company period ending 30/06/24
- 2025-03-25: Notice of agreement to exemption from audit of accounts for period ending 30/06/24
- 2024-07-13: Second filing for the appointment of Mr Jerome Marie Joseph Charton as a director
- 2024-05-16: Appointment of Mr Richard Edward Adair as a secretary on 30 April 2024
- 2024-05-16: Appointment of Mr Jerome Marie Joseph Charton as a director on 30 April 2024
- 2024-04-08: Audit exemption subsidiary accounts made up to 30 June 2023
- 2024-04-08: Consolidated accounts of parent company for subsidiary company period ending 30/06/23
- 2024-04-08: Notice of agreement to exemption from audit of accounts for period ending 30/06/23
- 2024-01-26: Termination of appointment of David John Bryant as a director on 26 January 2024
- 2023-05-03: Audit exemption subsidiary accounts made up to 30 June 2022
- 2023-05-03: Consolidated accounts of parent company for subsidiary company period ending 30/06/22
- 2023-05-03: Notice of agreement to exemption from audit of accounts for period ending 30/06/22

---

Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/quantum-pharma-holdings-09269818